Open AccessAbstract 1169: Novel renal medullary carcinoma cell lines, UOK353 and UOK360, provide preclinical tools to identify new therapeutics
Author(s) -
Darmood Wei,
Youfeng Yang,
Christopher J. Ricketts,
Cathy D. Vocke,
Mark W. Ball,
Carole Sourbier,
Darawalee Wangsa,
Danny Wangsa,
Rajarshi Guha,
Xiaohu Zhang,
Paul Meltzer,
Thomas Reid,
Craig J. Thomas,
María J. Merino,
W. Marston Linehan
Publication year - 2018
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2018-1169
Subject(s) - bortezomib , medicine , renal cell carcinoma , cancer research , proteasome inhibitor , clear cell , oncology , pathology , multiple myeloma